ROBERT I. LEHRER, M.D.; LEONARD S. GOLDBERG, M.D.; MARTIN A. APPLE, Ph.D.; N. PAUL ROSENTHAL, M.D.
LEHRER RI, GOLDBERG LS, APPLE MA, ROSENTHAL NP. Refractory Megaloblastic Anemia with Myeloperoxidase-Deficient Neutrophils. Ann Intern Med. 1972;76:447-453. doi: 10.7326/0003-4819-76-3-447
Download citation file:
Published: Ann Intern Med. 1972;76(3):447-453.
The enzyme myeloperoxidase contributes to the ability of human leukocytes to kill fungi and bacteria. We studied a 61-year-old man with megaloblastic anemia and two populations of neutrophils: 99.2% lacked myeloperoxidase activity; 0.8% had it. In vitro, these neutrophils had a greatly impaired ability to kill Staphylococcus aureus 502A, Candida albicans, and C. tropicalis. The patient developed fungal pneumonia (Aspergillus fumigatus and C. albicans) and, despite therapy with amphotericin B, died of systemic aspergillosis.
Learn more about subscription options.
Register Now for a free account.
Hematology/Oncology, Red Cell Disorders.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only